Condensed Consolidated Statements of Cash Flows (Unaudited) - USD ($)	3 Months Ended				6 Months Ended		12 Months Ended
	Dec. 31, 2025	Sep. 30, 2025	Dec. 31, 2024	Sep. 30, 2024	Dec. 31, 2025	Dec. 31, 2024	Jun. 30, 2025
Cash Flows From Operating Activities:
Net loss	$ (9,280,971)	$ (10,299,566)	$ (13,400,506)	$ (11,694,569)	$ (19,580,537)	$ (25,095,075)
Adjustments to reconcile net loss to net cash used in operating activities:
Depreciation expense					2,775,031	2,518,001
Accretion of financing costs					307,428	1,904,546
Amortization of right-of-use asset					61,274	52,315
Write-down of inventory to net realizable value					357,466	2,394,274
Stock-based compensation					5,531,468	9,502,030
Change in fair value of derivative liability						(705,184)
Change in fair value of conversion option						(138,060)
Change in fair value of liability-classified equity-linked contracts						(737,040)
Loss on debt extinguishment						675,648
Loss on private placement						567,161
Changes in operating assets and liabilities:
Accounts receivable					(1,369,919)	(95,476)
Inventory					(234,020)	(2,814,057)
Grants receivable					(205,810)	164,403
Prepaid expenses and other					(2,817,786)	1,285,820
Accounts payable and accrued liabilities					(1,714,369)	(2,053,400)
Operating lease liability					(55,611)	(241,884)
Net Cash Used in Operating Activities					(16,945,385)	(12,815,978)	$ (28,900,000)
Cash Flows From Investing Activities:
Purchase of mineral properties					(499,730)
Acquisition of property and equipment					(1,688,423)	(1,509,581)
Net Cash Used in Investing Activities					(2,188,153)	(1,509,581)
Cash Flows From Financing Activities:
Proceeds from issuance of common shares through At-The-Market offering					45,513,181	7,579,122
Payment of issuance costs of common shares through At-The-Market Offering					(354,269)
Proceeds from employee stock purchase plan					211,846	140,746
Proceeds from subscription agreements						1,900,000
Proceeds from registered direct offerings						15,000,000
Payment of issuance costs, registered direct offerings						(1,089,000)
Proceeds from exercise of share purchase warrants					9,983,020
Proceeds from notes payable, net of issuance costs						9,900,000
Principal paid on notes payable						(5,483,333)
Net Cash Provided by Financing Activities					55,353,778	27,947,535
Increase in Cash and Restricted Cash					36,220,240	13,621,976
Cash and Restricted Cash - Beginning of Period		$ 12,474,304		$ 7,001,786	12,474,304	7,001,786	7,001,786
Cash and Restricted Cash - End of Period	$ 48,694,544		$ 20,623,762		$ 48,694,544	$ 20,623,762	$ 12,474,304